PubMed Health⌕ Search

Biomedical subjects

Peter Kleinebudde

Publications and source records attributed to Peter Kleinebudde.

21 records · Page 2Linked to original sources

Quantum chemical descriptors in the formulation of pectin pellets produced by extrusion/spheronisation.

The objective of this study was to employ quantitative structure-activity relationships (QSAR) to relate calculated molecular descriptors of granulation liquid additives to improvements in the size of pectin pellets produced by extrusion/spheronisation. Quantum chemical descriptors were calculated for a large number of candidate additives. Based on a principal component analysis (PCA) of descriptors of the candidates, a few substances were selected. The most suitable concentration for each additive was found, and pellets were prepared by an extrusion/spheronisation process. Three pectin grades of different methoxy and amide substitution were tested and the quality of the pellets was evaluated based on size. PLS models were constructed to identify the molecular properties that were most important in producing short, nearly spherical pellets. The results show that quantum chemical descriptors can be a useful tool in the formulation of pectin pellets. Acceptable models relating additive properties and pellet size were achieved. Independent of the pectin grade, the two most important factors favouring formation of small spherical pellets were a small molecular size and a strong hydrogen bond forming ability of the additive molecules.

Chemistry, Pharmaceutical↗

Pectinic acid, a novel excipient for production of pellets by extrusion/spheronisation: preliminary studies.

A very low soluble pectin-derivative (pectinic acid, degree of methoxylation 4%) was found to be well suited as an excipient for pelletisation by extrusion/spheronisation. Formulations containing pectinic acid and lactose in the following ratios were evaluated: 99/1, 80/20, 50/50 and 20/80. The capacity as an extrusion aid was found to be high; even formulations containing only 20% pectinic acid resulted in nearly spherical pellets. All pectinic acid pellets were mechanically stable, had an aspect ratio of approximately 1.15-1.20 and released 30-60% of a low solubility model drug within 15 min both in simulated gastric acid (0.1M HCl) and intestinal fluid (phosphate buffer pH 6.8).

Chemistry, Pharmaceutical↗

Development of fast-disintegrating pellets in a rotary processor.

The aim of the present work was to formulate fast-disintegrating pellets by direct pelletization in a rotary processor. Formulations containing kaolin or bentonite and lactose were agglomerated with or without the addition of crospovidone in an instrumented rotary processor. The effects of the excipients on the amount of wall adhesion, the size and size distribution, the disintegration time, and the shape of the agglomerates, as well as the content of agglomerates > 2800 microns, were investigated. Further, pellets containing a model drug having a low aqueous solubility were prepared, and the drug dissolution profile was compared to that of pellets containing microcrystalline cellulose (MCC). Formulations containing kaolin resulted in fast-disintegrating pellets. Pellets containing bentonite eroded, but did not disintegrate, and the formulations gave rise to large amounts of wall adhesion. The addition of crospovidone increased the water content at the end of liquid addition for all formulations, and resulted in slightly more spherical agglomerates. When comparing formulations containing kaolin and MCC, kaolin gave rise to wider size distributions and a higher amount of agglomerates > 2800 microns, but the drug dissolution rate was much faster. Complete (100%) drug release was seen after 8 min with the kaolin formulation, whereas only 40% was released after 2 hr from the MCC formulation.

Bentonite↗